Literature DB >> 4031907

Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy.

N Ishii, Y Nishihara.   

Abstract

Eight cases of pellagra, diagnosed on the grounds of neuropathological findings and retrospective study of clinical data, were found among 106 necropsy cases of tuberculosis. Although these eight patients had shown various mental, neurological and gastrointestinal symptoms, as well as skin lesions, the diagnosis of pellagra had not been made clinically. In all the patients, pellagra symptoms appeared during isoniazid therapy. Death occurred 4 to 16 weeks later. Isoniazid inhibits the conversion of tryptophan to niacin and may induce pellagra, particularly in poorly nourished patients. Pellagra should be suspected whenever tuberculous patients under treatment with isoniazid develop mental, neurological or gastrointestinal symptoms, even in the absence of typical pellagra dermatitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031907      PMCID: PMC1028402          DOI: 10.1136/jnnp.48.7.628

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Neurological changes associated with P.A.S. and I.N.A.H. therapy.

Authors:  B G ADAMS; B M DAVIES
Journal:  J Ment Sci       Date:  1961-09

2.  Psychosis due to isoniazid.

Authors:  S L JACKSON
Journal:  Br Med J       Date:  1957-09-28

3.  Pellagra occurring in Africans under treatment for pulmonary tuberculosis.

Authors:  W S HAYNES
Journal:  East Afr Med J       Date:  1958-04

4.  Acute pellagra during isoniazid therapy.

Authors:  R B MCCONNELL; H D CHEETHAM
Journal:  Lancet       Date:  1952-11-15       Impact factor: 79.321

5.  Peripheral neuropathy due to isoniazid; report of two cases.

Authors:  W A JONES; G P JONES
Journal:  Lancet       Date:  1953-05-30       Impact factor: 79.321

6.  Pellagra and the nutritional neuropathies: a neuropathological review.

Authors:  D LEIGH
Journal:  J Ment Sci       Date:  1952-01

7.  Neurological manifestations in pellagra.

Authors:  D R Shah; S V Singh; I L Jain
Journal:  J Assoc Physicians India       Date:  1971-06

8.  Pellagra in Gulgarga.

Authors:  P S Shankar
Journal:  J Indian Med Assoc       Date:  1970-01-16

Review 9.  The etiology of pellagra and its significance for modern medicine.

Authors:  E Barrett-Connor
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

10.  Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases.

Authors:  N Ishii; Y Nishihara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

View more
  5 in total

1.  Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease.

Authors:  Istvan Kapas; Katalin Majtenyi; Klara Törö; Eva Keller; Till Voigtländer; Gabor G Kovacs
Journal:  Metab Brain Dis       Date:  2012-04-27       Impact factor: 3.584

2.  Psychiatric disturbance in mitochondrial encephalomyopathy.

Authors:  T Suzuki; J Koizumi; H Shiraishi; K Ofuku; M Sasaki; T Hori; N Oskoshi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

Review 3.  Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

Authors:  Lisa J Hill; Adrian C Williams
Journal:  Int J Tryptophan Res       Date:  2017-05-03

4.  Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid.

Authors:  Christopher Trent Brewer; Kiran Kodali; Jing Wu; Timothy I Shaw; Junmin Peng; Taosheng Chen
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

Review 5.  Severe Sleep Deprivation Causes Hallucinations and a Gradual Progression Toward Psychosis With Increasing Time Awake.

Authors:  Flavie Waters; Vivian Chiu; Amanda Atkinson; Jan Dirk Blom
Journal:  Front Psychiatry       Date:  2018-07-10       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.